Brookstone Capital Management Sells 32,570 Shares of Intuitive Surgical, Inc. $ISRG

Brookstone Capital Management decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 88.7% in the fourth quarter, Holdings Channel reports. The fund owned 4,137 shares of the medical equipment provider’s stock after selling 32,570 shares during the period. Brookstone Capital Management’s holdings in Intuitive Surgical were worth $2,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Riversedge Advisors LLC increased its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after purchasing an additional 17 shares during the period. Fiduciary Financial Group LLC boosted its stake in Intuitive Surgical by 2.1% during the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares during the period. Prosperity Consulting Group LLC boosted its stake in Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares during the period. Rossmore Private Capital grew its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after buying an additional 20 shares during the last quarter. Finally, Activest Wealth Management grew its holdings in Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ISRG. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a report on Wednesday, March 11th. The Goldman Sachs Group restated a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Finally, Argus reduced their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Trading Down 2.7%

Shares of ISRG stock opened at $452.07 on Friday. The stock has a 50 day moving average of $488.87 and a two-hundred day moving average of $512.97. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The company has a market capitalization of $160.54 billion, a P/E ratio of 57.30, a P/E/G ratio of 3.58 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.21 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,943 shares of company stock worth $17,279,568 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Motley Fool notes Intuitive “maintains edge” despite a March phishing breach — the report argues the incident exposed limited customer/contact data and does not materially impair the company’s core robotic-surgery platform or long-term growth thesis. Read More.
• Neutral Sentiment: The Zacks Analyst Blog flags mixed momentum for Intuitive alongside other large-cap names — the write-up highlights sector dynamics and does not change Intuitive’s longer-term narrative, but it signals cautious analyst tone. Read More.
• Neutral Sentiment: Kalkine Media reports a rating shift that put ISRG in focus on Nasdaq — the note drew trader attention but did not present new fundamental data; it likely amplified volatility as market participants reacted. Read More.
• Negative Sentiment: Coverage (Yahoo/Zacks) highlights growing pricing pressure in China as local rivals expand — analysts flag margin and unit-growth risk if Intuitive must defend share via pricing or increased commercial spend, even as the company leans on local manufacturing and its ecosystem to compete. Read More.
• Negative Sentiment: Zacks downgraded ISRG from “strong-buy” to “hold,” a direct analyst action that can prompt short-term selling and wider re-rating among momentum-driven investors. Read More.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.